[Significance of setting standards and guidelines for management of patients with hyperlipidemia].
作者信息
Kotake H, Oikawa S
机构信息
Tohoku CC Health Care Division, Japan Tobacco Inc.
出版信息
Nihon Rinsho. 2001 Mar;59 Suppl 3:492-9.
PMID:11347119
Abstract
摘要
相似文献
1
[Significance of setting standards and guidelines for management of patients with hyperlipidemia].
Nihon Rinsho. 2001 Mar;59 Suppl 3:492-9.
2
[Hyperlipidemia in patients with ischemic heart disease].
Nihon Rinsho. 2001 Mar;59 Suppl 3:722-7.
3
[Clinical trials on protective efficacy of statins for cardiovascular events due to hyperlipidemia (J-LIT, 4S, CARE, LIPID etc)].
Nihon Rinsho. 2004 Mar;62 Suppl 3:628-36.
4
[Treatment of hyperlipidemia].
Rinsho Byori. 2002 Mar;50(3):254-61.
5
[Clinical significance of primary and secondary prevention trials with lipid-lowering therapy against coronary heart disease].
Nihon Rinsho. 2001 Mar;59 Suppl 3:365-73.
6
[Practice guidelines review: Hyperlipidemia].
Nihon Naika Gakkai Zasshi. 2002 Apr 10;91(4):1250-6.
7
Lipoprotein analysis.
Adv Nurse Pract. 2002 May;10(5):30-2.
8
[What other effects do statins have except their effect on lipids?].
Duodecim. 1998;114(13):1299-301.
9
The 2003 Canadian recommendations for dyslipidemia management: revisions are needed.
CMAJ. 2005 Apr 12;172(8):1027-31. doi: 10.1503/cmaj.1040202.
10
[Lipid determination in current medical practice].
Ann Dermatol Venereol. 1986;113(9):855-9.
Zotero 插件